Bookmark

Add to MyYahoo RSS

Eli Lilly News

News on Eli Lilly (Ticker: LLY) continually updated from thousands of sources around the net.

5 hrs ago | AmericanBankingNews.com

Eli Lilly and Price Target Increased to $60.00 by Analysts at Jefferies Group

The firm currently has a "hold" rating on the stock. Jefferies Group's price objective suggests a potential upside of 0.74% from the company's current price.

Comment?

Related Topix: Alnara Pharmaceuticals, Biotech, Food, Medicine, Avid Radiopharmaceuticals, Agriculture, International Multifoods Corporation, Eli Lilly, Imclone Systems, Healthcare Industry

20 hrs ago | Lincoln Daily News

Lilly eyes emerging markets in Novartis animal-health deal

The purchase of Novartis' animal-health business will strengthen Eli Lilly's hand in emerging markets, tapping into growing demand there for protein-rich diets and household treatments for pets, top executives of the U.S. company said.

Comment?

Related Topix: Biotech, Medicine, Eli Lilly, Healthcare Industry

Tue Apr 22, 2014

The Indianapolis Star

Eli Lilly's $5.4B acquisition will boost Elanco

Drug maker Novartis says it has signed several multibillion-dollar deals with GlaxoSmithKline and Eli Lilly & Co.

Comment?

Related Topix: Biotech, Novartis, Medicine, Eli Lilly, Healthcare Industry, GlaxoSmithKline

Mon Apr 21, 2014

Reuters

Eli Lilly to buy Novartis' animal health business for $5.4 bln

Eli Lilly and Co said on Tuesday it will buy Novartis AG's animal health business for $5.4 billion in cash to strengthen and diversify its Elanco unit.

Comment?

Related Topix: Biotech, Eli Lilly, Medicine, Healthcare Industry

The Indianapolis Star

FDA approves new Eli Lilly drug to treat stomach cancer

Eli Lilly and Co. corporate headquarters at Delaware and McCarty streets in Downtown Indianapolis.

Comment?

Related Topix: Biotech, Medicine, Eli Lilly, Healthcare Industry, Indianapolis, IN, Imclone Systems

PR-inside.com

Eli Lilly to Speak at Metabolomics Meeting, May 22-23 2014, Cambridge, MA

Cross-platform Omics Data Integration in Ingenuity Systems" at the Inaugural Metabolomics Conference - Advances & Applications in Human Disease to be held in Cambridge, MA on May 22-23, 2014 by GTCBio.

Comment?

Related Topix: Biotech, Medicine, Eli Lilly, Healthcare Industry, Startups, Ingenuity Systems, Diabetes, Health, Chemistry, Science

Tue Apr 15, 2014

Pharmaceutical Online

Lilly Invests Millions On New Anti-Counterfeiting Serialization Program

Over the next two years, Eli Lilly will be strengthening its efforts against counterfeiting with a $110 million investment in a new serialization program for its drug packages.

Comment?

Related Topix: Biotech, Medicine, Eli Lilly, Healthcare Industry

Mon Apr 14, 2014

Drugs.com

Boehringer Ingelheim and Eli Lilly Announce NDA Filing for Empagliflozin and Linagliptin Combination

Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced the U.S. Food and Drug Administration accepted the filing of the New Drug Application for the investigational combination tablet of empagliflozin and linagliptin for the treatment of adults with type 2 diabetes .

Comment?

Related Topix: Biotech, Medicine, Eli Lilly, Healthcare Industry, Food and Drug Administration, Diabetes, Health, Insulin (generic), Humulin, Novolin

Wall Street Journal

Eli Lilly vs. Canada: The Patent War Moves to Washington

Its efforts underscore growing frustration the pharmaceutical industry has toward some foreign governments over patent rights, although much of the vitriol has often been directed toward India.

Comment?

Related Topix: Biotech, Medicine, Eli Lilly, Healthcare Industry

AmericanBankingNews.com

Eli Lilly and Upgraded to "Hold" by Jefferies

The firm currently has a $54.00 target price on the stock, up from their previous target price of $45.00.

Comment?

Related Topix: Alnara Pharmaceuticals, Biotech, Food, Medicine, Avid Radiopharmaceuticals, Agriculture, International Multifoods Corporation, Eli Lilly, Imclone Systems, Healthcare Industry

AmericanBankingNews.com

Eli Lilly and PT Raised to $54.00

The firm currently has a "hold" rating on the stock. A number of other analysts have also recently weighed in on LLY.

Comment?

Related Topix: Alnara Pharmaceuticals, Biotech, Food, Medicine, Avid Radiopharmaceuticals, Agriculture, International Multifoods Corporation, Eli Lilly, Imclone Systems, Healthcare Industry

Fri Apr 11, 2014

Freshnews

Lilly Confirms Date and Conference Call for First-Quarter 2014 Financial Results Announcement

Eli Lilly and Company will announce its financial results for the first quarter of 2014 on Thursday, April 24, 2014.

Comment?

Related Topix: Biotech, Medicine, Eli Lilly, Healthcare Industry

Thu Apr 10, 2014

Big News Network.com

Takeda and Eli Lilly to appeal $9bn punitive damages ordered by court

Our eNewspaper network was founded in 2002 to provide stand-alone digital news sites tailored for the most searched-for locations for news.

Comment?

Related Topix: Biotech, Medicine, Eli Lilly, Healthcare Industry, Actos, Pioglitazone (generic), Diabetes, Health, bladder cancer

Palladium-Item

Indiana lawmakers weigh in on drug patent dispute

Indiana lawmakers want the Obama administration to increase pressure on Canada over the country's handling of pharmaceutical patents.

Comment?

Related Topix: Indiana, Biotech, Medicine, Eli Lilly, Healthcare Industry

Business Journal

Biotech company's progress brings cash, new CEO

A Kansas biotech company said it has new money, and a new CEO, as one of its cancer treatment drugs progressed to Phase I clinical trials.

Comment?

Related Topix: Cancer, Medicine, Health

Wed Apr 09, 2014

The Japan Times

Pharmaceutical giant Takeda to fight $6 billion damages ruling by...

Takeda Pharmaceutical Co. said it would contest $6 billion in punitive damages imposed by a jury in the United States in a case that accused Japan's largest drugmaker of concealing cancer risks associated with its Actos diabetes drug.

Comment?

Related Topix: Medicine, Diabetes, Health, Biotech, Eli Lilly, Healthcare Industry, 9, Exxon Mobil, Energy, Oil & Gas, US News, US Supreme Court

Tue Apr 08, 2014

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

Johnson comes to Bizwom... )--A U.S. jury's combined $9 billion judgment against Japan's Takeda Pharmaceutical partner company Eli Lilly will not affect LLY's ratings, according to Fitch Ratings... )--FUND db x-trackers Stoxx Europe 600 Technology UCITS ETF DEALING DATE 7-Apr-14 NAV PER SHARE EUR39.7009 NUMBER OF SHARES IN ISSUE 310,533 CODE ... (more)

Comment?

Related Topix: Biotech, Medicine, Eli Lilly, Healthcare Industry, Manufacturing, AB Electrolux, Saab AB, Appliances, Aerospace-Defense

WTHR-TV Indianapolis

US jury hits Eli Lilly, Takeda with $9B penalty

Testifying in his murder trial on Tuesday, Oscar Pistorius said he and girlfriend Reeva Steenkamp sometimes had troubles in their relationship but that they sorted them out, were in love and were planning Testifying in his murder trial on Tuesday, Oscar Pistorius said he and girlfriend Reeva Steenkamp sometimes had troubles in their relationship ... (more)

Comment?

Related Topix: Biotech, Medicine, Eli Lilly, Healthcare Industry, Indianapolis, IN, Drugs

Mon Apr 07, 2014

The Washington Post

Takeda, Lilly Jury Awards $9 Billion Over Hiding Actos Risks

Takeda Pharmaceutical Co. and Eli Lilly & Co. were ordered to pay a combined $9 billion after a federal court jury found they hid the cancer risks of their Actos diabetes medicine in the first U.S. trial of its kind.

Comment?

Related Topix: Actos, Pioglitazone (generic), Medicine, Biotech, Eli Lilly, Healthcare Industry, Diabetes, Health, Lafayette, LA

Customer Interaction Solutions

Deciphera Pharmaceuticals Announces Initiation of Phase 1 Cancer Trial for LY3009120

Deciphera Pharmaceuticals, a clinical stage biotechnology company focused on improved kinase inhibitor treatments for cancer, today announced the initiation of a Phase 1 clinical trial of its pan-RAF inhibitor LY3009120 , under development in collaboration with Eli Lilly.

Comment?

Related Topix: Biotech, Eli Lilly, Medicine, Healthcare Industry, Oncology

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••
•••